NASHVILLE, Tenn., May 26, 2021 /PRNewswire/ -- OneOncology, the platform for independent oncology practices, said today that partner practice physicians and other OneOncology experts will make 23 presentations across 12 different subject categories at the 2021 ASCO Annual Meeting from June 4-6.
Lee Schwartzberg, MD, Chief Medical Officer, OneOncology, is an author on six abstracts and Axel Grothey, MD, Medical Director, OneR, Director of GI Cancer Research at the West Cancer Center, is the author on 12 abstracts. OneR is OneOncology's clinical trial site management organization launched last year.
Drs. Grothey, Schwartzberg and Ari VanderWalde, Medical Director of Precision Oncology at OneR and Director of Research at West Cancer Center are authors on an abstract evaluating targeted therapies in patients who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response as part of Genentech's basket clinical trial, MyTACTIC. The trial aims to match patient populations with a targetable genomic alteration to a specific investigational agent. Dr. Grothey is the lead author on the abstract.
West Cancer Center investigator, Daniel Vaena, MD, is the lead author of an abstract selected for oral presentation. Dr. Vaena's abstract presentation will discuss the results of an ongoing phase 1 study of safety, tolerability and preliminary antitumor activity in patients with advanced solid malignancies.
Another highlight amongst the body of research presented at ASCO is an abstract that examines the impact of clinical trial enrollment on episode costs in Medicare's Oncology Care Model. Garrett Young, Director, Clinical & Strategic Analytics, OneOncology is the lead author on this abstract selected for a poster discussion in the Health Services Research and Quality Improvement category. Being selected for a poster discussion recognizes the abstract as one of the top 12 in the topic area.
Originally published by OneOncology >>
Clinical Trials and New Techniques Advance the Bladder Cancer Treatment Landscape
May 31st 2023For Bladder Cancer Awareness Month, Jahan Aghalar, MD, discussed the latest advancements in treating patients with bladder cancer along with which targets have helped to push the field forward.
Read More
New Technologies, Holistic Treatment Approaches for Brain Cancer Emerging
May 17th 2023For Brain Cancer Awareness Month, Charles Redfern, MD, discussed the biggest technological changes to treatment for adult patients with brain cancer and how holistic treatment remains important for treating this challenging disease.
Read More
Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology
August 9th 2021In an interview with Targeted Oncology™, Statish Shah, MD, the medical director of Gettysburg Cancer Center, discusses the OneOncology partnership in more detail and how it will benefit patients.
Read More